Shine Investment Advisory Services’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$1K Hold
36
﹤0.01% 697
2020
Q2
$1K Hold
36
﹤0.01% 706
2020
Q1
$0 Sell
36
-54
-60% -$1.51K ﹤0.01% 719
2019
Q4
$3K Hold
90
﹤0.01% 689
2019
Q3
$4K Hold
90
﹤0.01% 665
2019
Q2
$5K Sell
90
-829
-90% -$48.6K ﹤0.01% 614
2019
Q1
$63K Sell
919
-182
-17% -$12.2K 0.03% 263
2018
Q4
$66K Sell
1,101
-280
-20% -$24.2K 0.03% 230
2018
Q3
$160K Buy
1,381
+16
+1% +$1.8K 0.08% 122
2018
Q2
$172K Hold
1,365
0.09% 119
2018
Q1
$148K Buy
1,365
+16
+1% +$1.77K 0.08% 116
2017
Q4
$148K Sell
1,349
-63
-4% -$6.29K 0.07% 113
2017
Q3
$139K Buy
1,412
+93
+7% +$9.02K 0.07% 123
2017
Q2
$134K Buy
+1,319
New +$142K 0.07% 118

Other funds holding CLB

Shine Investment Advisory Services's CLB Position: Q3 2020 in Review

Shine Investment Advisory Services held its Core Laboratories (CLB) position steady in Q3 2020 at 36 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #697.

Shine Investment Advisory Services first reported a position in CLB in Q2 2017 and has held it in 14 quarters since. The position peaked at $172K in Q2 2018. 187 funds tracked by Wall St. Rank hold CLB as of Q3 2020.

  • Shine Investment Advisory Services held 36 shares of Core Laboratories worth $1K as of Q3 2020.
  • Shine Investment Advisory Services left its Core Laboratories share count unchanged in Q3 2020.
  • Core Laboratories made up ﹤0.01% of Shine Investment Advisory Services's portfolio in Q3 2020, its #697 holding.
  • Shine Investment Advisory Services first reported a position in Core Laboratories in Q2 2017 and has held it in 14 quarters since.
  • Shine Investment Advisory Services's Core Laboratories position peaked at $172K in Q2 2018.
  • 187 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2020.

Based on Shine Investment Advisory Services's 13F filing for Q3 2020, filed 3 Nov 2020.